Trials / Completed
CompletedNCT05612958
Efficacy and Safety of a 'Graft/Prosthesis, Biomaterial (DKM410)' in the Treatment of Both Nasolabial Folds
Efficacy and Safety of a 'Graft/Prosthesis, Biomaterial (DKM410)' in the Treatment of Both Nasolabial Folds: Single Center, Prospective, Comparative, Randomized, Double Blinded (Subject, Evaluator), Matched Pairs Design, Non-inferiority, Pivotal Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 82 (actual)
- Sponsor
- Dongkook Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess the efficacy and safety of a 'Graft/prosthesis, biomaterial (DKM410)' in the treatment of both nasolabial folds.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DKM-410 | Injection up to 2.0ml |
| DEVICE | Juvederm ULTRA PLUS XC 1.0ml | Injection up to 2.0ml |
Timeline
- Start date
- 2021-03-23
- Primary completion
- 2022-01-14
- Completion
- 2022-06-28
- First posted
- 2022-11-10
- Last updated
- 2022-11-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05612958. Inclusion in this directory is not an endorsement.